Abstract:This paper considers the expected experiment times for Weibull-distributed lifetimes under type II progressive censoring, with the numbers of removals being random. The formula to compute the expected experiment times is given. A detailed numerical study of this expected time is carried out for different combinations of model parameters. Furthermore, the ratio of the expected experiment time under this type of progressive censoring to the expected experiment time under complete sampling is studied.
“…Moreover, this shows that these models are mixture models with mixing pmf g * m . This approach corresponds to progressive censoring models with random removals according to a probability distribution g * (see, for instance, Yuen and Tse 1996, Tse and Yuen 1998, Tse et al 2000, Tse and Xiang 2003, and Tse and Yang 2003. Such a scheme is called a simple adaptive progressive censoring scheme.…”
Section: Description Of the Model And Special Submodelsmentioning
“…Moreover, this shows that these models are mixture models with mixing pmf g * m . This approach corresponds to progressive censoring models with random removals according to a probability distribution g * (see, for instance, Yuen and Tse 1996, Tse and Yuen 1998, Tse et al 2000, Tse and Xiang 2003, and Tse and Yang 2003. Such a scheme is called a simple adaptive progressive censoring scheme.…”
Section: Description Of the Model And Special Submodelsmentioning
“…An application of progressive censoring was reported in [13] for studying the performance of electronic components where some test units had to be removed due to excessive heat. Tse and Yuen [14], Tse et al [15], and Yuen and Tse [16] investigated the problems of parameter estimation and the expected experiment time under this type of censoring with random removals. In particular, Tse and Yang [17] investigated reliability sampling plans under Type II progressive censoring with random removals.…”
This paper considers the design of accelerated life test (ALT) sampling plans under Type I progressive interval censoring with random removals. We assume that the lifetime of products follows a Weibull distribution. Two levels of constant stress higher than the use condition are used. The sample size and the acceptability constant that satisfy given levels of producer's risk and consumer's risk are found. In particular, the optimal stress level and the allocation proportion are obtained by minimizing the generalized asymptotic variance of the maximum likelihood estimators of the model parameters. Furthermore, for validation purposes, a Monte Carlo simulation is conducted to assess the true probability of acceptance for the derived sampling plans.
“…However, in some practical situations, these numbers may occur at random. Tse and Yuen (1998) indicated that, for example, the number of patients drop out from a clinical test at each stage is random and cannot be pre-determined. In some reliability experiments, an experimenter may decide that it is inappropriate or too dangerous to carry on the testing on some of the tested units even though these units have not failed.…”
This study considers the estimation problem for the Pareto distribution based on progressive Type II censoring with random removals, where the number of units removed at each failure time has a uniform distribution. We use the maximum likelihood method to obtain the estimators of parameters and the distributions of the estimators are derived. We also construct the confidence intervals for the parameters and percentile of the lifetime distribution. The expected time required to complete this censoring test is computed. Some numerical results of expected test times are carried out for this type of progressive censoring and other sampling schemes.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.